Immediate Impact

3 from Science/Nature 81 standout
Sub-graph 1 of 21

Citing Papers

Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study
2024 Standout
Reteplase versus Alteplase for Acute Ischemic Stroke
2024 Standout
2 intermediate papers

Works of Gary Hantsbarger being referenced

Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration
2006
Differential Dose-Response to Oral Xemilofiban After Antecedent Intravenous Abciximab
1996
and 1 more

Author Peers

Author Last Decade Papers Cites
Gary Hantsbarger 178 71 173 404 280 19 760
Ming-Shan He 147 31 222 61 58 20 931
Pouya N. Dayani 33 8 25 533 279 17 731
A Goguel 26 27 15 267 325 27 877
G. Alistair Lammie 124 62 101 30 156 19 980
J Lanham 108 56 49 62 49 19 675
Carola Metzig 16 5 94 184 175 15 693
Steven R. Bennett 39 94 8 671 439 24 917
Christopher Liu 46 49 18 150 329 19 650
Alec Garner 127 51 12 314 212 27 681
J.M.M. Groenewoud 27 68 23 689 436 35 977

All Works

Loading papers...

Rankless by CCL
2026